Introduction
Staphylococcus aureus is one of the most common Grampositive bacteria in sepsis [1] . During severe sepsis and septic shock, a massive release of cytokines and activation of the coagulation system result in disseminated intravascular coagulation (DIC) and multiorgan dysfunction syndrome [2±5] .
Monocytes and endothelial cells possess potential thrombogenic properties through their ability to express tissue factor (TF). TF, a single-chain transmembrane protein composed of 263 amino acid residues, is recognized as the major physiological initiator of blood coagulation [6] . TF binds to plasma factor (F)VII, forming a potent procoagulant complex, which in its turn can rapidly activate FIX and FX. Activated FX converts prothrombin into thrombin that subsequently converts soluble ®brinogen into insoluble ®brin [7] . Monocytes do not constitutively express TF but can be stimulated to do so by lipopolysaccharides (LPS), and peptidoglycan, components of the outer cell wall of Gram-negative and Gram-positive bacteria, respectively [8, 9] . Since monocytes are the only peripheral blood cells capable of expressing TF, there has been considerable interest in measuring the procoagulant activity (PCA) of these cells, under pathophysiological conditions [3, 10] .
Gram-positive bacteria can trigger sepsis and septic shock by at least two mechanisms. Whole bacteria or cell wall components such as peptidoglycan, teichoic acid and lipoteichoic acid can activate a sequence of processes culminating in septic shock [1] . Furthermore, many Gram-positive bacteria produce exotoxins that activate several pathways involved in sepsis [11] . S. aureus can release toxins that are classi®ed as superantigens, meaning that they can induce broad-spectrum T-cell activation without antigen speci®city. Bacterial superantigens interact directly with MHC class II molecules on antigen-presenting cells, and in this context they stimulate T cells bearing particular variable-region b-chain elements irrespective of the other variable components of the T-cell receptors. As a result of the binding of superantigens, both antigen-presenting cells and T cells become activated [12, 13] . Toxic shock syndrome toxin (TSST)-1 is considered the major cause of toxic shock syndrome, which is characterized by fever, hypotension, a scarlatiniform rash, and the involvement of at least three major organ systems [14±16]. TSST-1 is unique in its ability to pass through mucosal surfaces [17] . Other staphylococcal superantigens are the enterotoxins: A, B, Cn, D, E and M [17] . These cause staphylococcal food poisoning syndrome and some of them also toxic shock syndrome [1, 14] .
Recently, we showed that intact S. aureus bacteria and staphylococcal peptidoglycan induced PCA and TF expression in human monocytes [9] . Some S. aureus strains produce soluble superantigens that have potent effects on the immune system without any presence of bacteria in the circulating blood [17] . Therefore, the present investigation was stimulated by the hypothesis that staphylococcal superantigens could induce TF production in human monocytes. In this study, we demonstrate that enterotoxin A (EA), enterotoxin B (EB), and TSST-1 from S. aureus induce PCA and TF expression in human monocytes. Furthermore, we show that the induction of TF expression is mainly induced via released interleukin (IL)-1b.
Materials and methods

Special reagents
Polymyxin B, LPS from Escherichia coli strain O111:B4, EA, EB, and TSST-1 (lot no 071K4107, 110K4080 and 071K4108, respectively) were purchased from Sigma (St Louis, MO, USA). The purity of the toxins was con®rmed by SDS electrophoresis. No signi®cant contamination of EA or EB was detected in the EB and EA preparations, respectively. In addition, toxininduced PCA in peripheral blood mononuclear cells (PBMC) and whole blood was the same both in the absence and presence of polymyxin B during incubations, excluding the presence of contaminating endotoxins. Citrated blood and plasma were obtained from healthy volunteers after informed consent. Goat antihuman TF immunoglobulin G (IgG) was a kind gift from Dr M. Kjalke (Novo Nordisk, Copenhagen, Denmark), and IgG puri®ed from a goat immunized with human b 2 -microglobulin was used as a control. Human recombinant tumor necrosis factor (TNF)-a, IL-1b, interferon (IFN)-g, IL-1 receptor antagonist (IL-1Ra) and neutralizing monoclonal antibodies (MoAb) against TNF-a were from R&D (Abingdon, UK).
Isolation of human PBMC
PBMC were isolated essentially as previously described [9] . In short, PBMC were removed by centrifugation over Ficoll± Paque (Pharmacia Biotech, Uppsala, Sweden). The PBMC consisted of 27 AE 6% (mean AE SD) monocytes and 73 AE 7% lymphocytes, as judged by¯ow cytometry, using side scatter and forward scatter characteristics and labelling of the cells by a combination of CD45 and CD14 monoclonal antibodies (Dakopatts, Glostrup, Denmark). The viability of the cells was >99% as judged by trypan blue exclusion.
Stimulation of PBMC or whole blood and determination of PCA PBMC were resuspended in CO 2 -Independent Medium (Invitrogen, Lidingo È, Sweden), and 250 mL cell suspensions (2.5 Â 10 6 cells mL À1 ) to which 50 mL of stimuli dissolved in medium were added, and incubated on a rotator at 37 8C for 8 h, if not otherwise indicated. To exclude endotoxin contamination during the experiment, the toxins were preincubated with polymyxin B at a ®nal concentration of 20 mg mL À1 for 30 min, before they were added to PBMC. After thawing, 100 mL of plasma were incubated with 100 mL of 30 mM CaCl 2 in 1% bovine serum albumin at 37 8C for 1 min in a coagulometer (Amelung, Lemgo, Germany). Thereafter, 100 mL of cell suspension were added, and PCA was determined. All samples were analyzed in duplicate.
Whole blood (600 mL) was incubated with the different toxins (preincubated with polymyxin B as mentioned above), or LPS, 50 mL in Eppendorf tubes, with holes in the coverings to allow gas exchange, in 5% CO 2 at 37 8C for different time periods according to Santucci et al. [18] . After vortexing, 300 mL of blood were transferred to the coagulometer and recalci®ed with 40 mL of 100 mM CaCl 2 and clotting time was determined in the coagulometer. The responsiveness of recalci®ed plasma and whole blood to TF-induced coagulation was con®rmed by the use of relipidated TF (Sigma). Standard curves were performed by adding increasing concentrations of puri®ed TF to recalci®ed plasma and whole blood, respectively, whereafter clotting time was determined in the coagulometer. All samples were analyzed in duplicate. In experiments including anti-TF IgG, PBMC or whole blood was incubated with stimulus for 8 and 24 h, respectively. Thereafter, anti-TF IgG or control IgG was added to the cell suspension or blood sample (at a ®nal concentration of 55 mg mL À1 ), and incubated for another 30 min before analysis of PCA.
Detection of TF expression by flow cytometry
PBMC were incubated as described above in the absence or presence of toxins for 16 h. After incubation, the cells were put on ice and ®xed with paraformaldehyde at a ®nal concentration of 1% (w/v). Thereafter, the cells were incubated with a mixture of a phycoerythrin-conjugated monoclonal antibody against CD14 (Dakopatts) and a¯uorescein isothiocyanate (FITC)-conjugated monoclonal antibody against TF (American Diagnostica, Greenwich, CT, USA) or, as a control, CD14 antibody and an isotype-matched FITC-conjugated irrelevant monoclonal antibody (monoclonal antibody IgG1; Immunotech, Marseille, France) at the same concentration as the TF antibody. Monocytes were gated by their characteristics in side scatter and forward scatter, and their identity was further con®rmed by their characteristic expression of CD14. The mean¯uorescence intensity (MFI) for the control antibody, representing background, was subtracted from the MFI for the TF antibody.
Determination of TNF-a and IL-1b by ELISA PBMC were incubated in the presence or in the absence of toxins as described above. Thereafter, the cells were spun down (10 000 g, 10 min) and the supernatants were collected and stored at À70 8C until analyzed for their content of TNF-a and IL-1b in the supernatants by ELISA (R&D). The detection limit of both assays was 4 pg mL À1 .
Statistical analysis
For statistical analysis, one-way repeated measures analysis of variance was used, followed by Dunnett's-test when appropri-ate. A value of P < 0.05 was considered to be statistically signi®cant.
Results
EA, EB, and TSST-1 induce PCA in whole blood
EA, EB, TSST-1, and LPS were incubated with whole blood at various concentrations for 24 h. Subsequently, the blood was recalci®ed and the clotting time was determined. EA, EB and TSST-1 all induced PCA. EB and TSST-1 were weaker stimuli than EA (Fig. 1A) . The lowest concentrations of toxins that caused signi®cantly increased PCA were 100 ng mL À1 (EA, EB) and 1 mg mL À1 (TSST-1). LPS, used as a positive control, was much more potent on a weight basis than the toxins, showing a signi®cantly increased PCA already at 1 ng mL À1 .
In order to study the kinetics of the increase in PCA induced by the toxins, whole blood was incubated with toxins or LPS (1 mg mL À1 ) for different time intervals before recalci®cation of the blood and determination of clotting time. After 4 h incubation, no signi®cant change in clotting time was observed in blood samples incubated with toxins, in contrast to LPS-stimulated blood, where a reduction in clotting time of 50% was observed (Fig. 1B) . After 24 h of incubation, there was an increased PCA in blood stimulated with EA, EB and TSST-1, being most pronounced for EA. After another 24 h, i.e. 48 h of incubation, the PCA had increased further in staphylococcal toxin-stimulated blood, while LPS-stimulated blood reached a plateau with regard to PCA after 24 h of incubation. In the control, whole blood incubated with medium alone, no signi®cant effects were observed.
Staphylococcal toxins induce PCA in PBMC EA, EB, or TSST-1 at various concentrations, were incubated with human PBMC (2.5 Â 10 6 cells mL À1 ) for 8 h. Subsequently, the suspension was added to recalci®ed human plasma, and the clotting time was analyzed. Figure 2A shows that PCA was induced in a concentration-dependent fashion by the staphylococcal toxins with a threshold concentration at 1 ng mL À1 . In accordance with the experiments using whole blood, LPS was again a more potent inducer of PCA compared with the toxins. To investigate the kinetics of the PCA induced by the toxins, PBMC were incubated with 1 mg mL À1 of the toxins for different time intervals before determination of the clotting time. The data show that the toxin-induced PCA by PBMC is a rapid process with signi®cant changes of PCA after 4 h of incubation (Fig. 2B) . In order to exclude that endotoxins were contaminating the puri®ed preparations of superantigens, thereby causing the PCA, the toxins were preincubated with polymyxin B (an antibiotic which neutralizes endotoxin) before the addition of toxins to PBMC or blood. Polymyxin B effectively inhibited the effect of 100 ng mL À1 LPS in the PCA assay but did not affect the PCA induced by the toxins (data not shown).
Expression of TF by monocytes is necessary for the PCA induced by staphylococcal toxins in PBMC and whole blood
To investigate whether TF was responsible for the PCA, TFneutralizing IgG or control IgG was added to toxin-stimulated PBMC or whole blood after 4 h and 24 h of incubation, respectively, and thereafter incubated for another 30 min followed by determination of PCA. Anti-TF IgG effectively inhibited the increased PCA of toxin-stimulated PBMC and whole blood, showing that the PCA was dependent on TF expression (Fig. 1C) . Clotting time of plasma, which had been incubated with EA-stimulated PBMC in the presence of medium, anti-TF IgG Fig. 2 . Enterotoxin A (EA), enterotoxin B (EB) and toxic shock syndrome toxin (TSST)-1 induce procoagulant activity (PCA) and tissue factor (TF) expression in peripheral blood mononuclear cells (PBMC). (A) PBMC were incubated with medium alone or the indicated concentrations of EA, EB, TSST-1, or lipopolysaccharide (LPS) for 8 h. Clotting time was determined after exposure of the cells to recalci®ed plasma. (B) PBMC were incubated with medium alone or EA, EB, TSST-1, or LPS (1 mg mL À1 ) for the indicated time periods. Subsequently, the cells were exposed to recalci®ed human plasma, and the clotting time was determined. Values are means AE SD (n 3). Ã P < 0.05. or control IgG was 217 AE 104, 555 AE 82 and 226 AE 75 s (mean AE SD, n 4), respectively. Using¯ow cytometry, it was found that TF was expressed on the surface of EA-and TSST-1-stimulated monocytes (EB was not tested). CD14 was used to verify the phenotype of monocytes, con®rming that only monocytes expressed TF after stimulation with EA and TSST-1 (Fig. 3) .
Toxin-induced TF expression in monocytes is dependent on the release of IL-1b
Since superantigens from S. aureus can induce expression of TNF-a, IL-1b and IFN-g in human PBMC, and these cytokines have the ability to induce TF expression in monocytes [15,19± 22] , it is a possibility that the toxin-induced PCA is caused by auto-and paracrine effects from these cytokines. To investigate this, PBMC (2.5 Â 10 6 cells mL À1 ) were incubated with human recombinant TNF-a, IL-1b, or IFN-g for 4 h. In our hands, TNF-a and IL-1b both induced PCA in PBMC in a concentration-dependent fashion, while IFN-g did not, despite the high concentrations tested (33 ng mL À1 ) (Fig. 4A ). TNF-a and IL-1b were equally potent and about 500 pg mL À1 of the cytokines reduced the clotting time by 50% compared with the control (PBMC without stimulus). Thereafter, the cytokine content of supernatants from toxin-stimulated PBMC was investigated. PBMC were stimulated with toxins (1 mg mL À1 ) for 4 h, subsequently TNF-a and IL-1b of the supernatants were determined by ELISA. EA, EB, and TSST-1 all induced IL-1b release from PBMC (Fig. 4B) . Surprisingly, we could detect only low levels of TNF-a (in the order of 20±60 pg mL À1 ) in the supernatants (data not shown).
To determine the role of IL-1b in toxin-induced TF expression in human monocytes, PBMC were incubated with IL-1b (500 pg mL À1 ), EA (1 mg mL À1 ), or TSST-1 (1 mg mL À1 ) in the presence or absence of IL-1Ra (100 ng mL À1 ), the naturally occurring inhibitor of IL-1 [23] . IL-1Ra was an ef®cient inhibitor of the PCA induced by IL-1b (control), EA and TSST-1 (Figs 3 and 4C ), suggesting that the induction of PCA by staphylococcal toxins is mainly mediated via released IL-1b.
Discussion
Recent years of research have shown that coagulation is part of the innate immune system and during the progression of an infection, components released from the microbe can modulate the procoagulant and anticoagulant equilibrium of the host [24] . This sometimes leads to severe complications, such as disseminated intravascular coagulation combined with high mortality rates [25] . Most studies addressing this problem have been performed with LPS from the Gram-negative pathogen E. coli. In contrast, the molecular mechanisms behind Gram-positive sepsis are poorly understood. Thus, the present study aimed at investigating staphylococcal superantigens in their ability to trigger TF activity in monocytes. In the present study, we show that superantigens from S. aureus induce PCA in PBMC mainly via the release of IL-1b, thereby linking the in¯ammatory response elicited by the superantigens to expression of TF and procoagulant activity in monocytes.
The clotting assays used re¯ect ®brin formation in whole blood and plasma. Puri®ed relipidated TF produced a typical dose±response curve, showing that the assays indeed are sensitive to TF (data not shown). Toxin stimulation of both whole blood and PBMC resulted in a shortening of clotting times, probably re¯ecting increased TF activity. Addition of neutralizing TF antibodies con®rmed that the shortening in clotting times was certainly caused by toxin-stimulated TF activity. The advantage of the clotting assay is that functional TF is determined while FACS and ELISA measure the TF antigen levels Fig. 3 . Enterotoxin A (EA) and toxic shock syndrome toxin (TSST)-1 induce tissue factor (TF) expression on the surface of monocytes. Inhibition by interleukin-1 receptor antagonist (IL-1Ra). Peripheral blood mononuclear cells (PBMC) were incubated in medium alone, EA (1 mg mL À1 ), TSST-1 (1 mg mL À1 ), or IL-1b (500 pg mL À1 ) in the absence or presence of IL-1Ra (100 ng mL À1 ) for 16 h. Cells were then incubated with phycoerythrin-conjugated CD14, FITC-conjugated TF, or isotypematched control antibodies and assayed by¯ow cytometry. (A) Monocytes (Mù) were gated using their characteristics in forward scatter and expression of CD14. (B) EA and TSST-1 increased TF expression on the surface of monocytes compared with cells incubated in medium alone. Addition of IL-1Ra reduced the increase in TF expression caused by EA and TSST-1, showing that TF expression is dependent on IL-1. As a control, cells were incubated with IL-1b, in the absence or presence of IL-1Ra, showing that IL-1b induces TF expression in monocytes and that IL-1Ra inhibits the effect. One experiment representative of ®ve is shown. # 2003 International Society on Thrombosis and Haemostasis that may not correlate with levels of functional TF activity due to encryptation [26] . The increase in PCA induced by the staphylococcal toxins should therefore re¯ect an upregulation of TF on the cell surface. However, a remodeling of the phospholipid composition of the outer lea¯et of the cells by the toxins or IL-1b could contribute to the effect [26] . However, a clear distinction is not possible at the moment and further experiments are required to address this question.
The threshold dose of toxin needed to generate PCA was higher in whole blood compared with PBMC incubations. Also the time kinetics was different comparing toxin-stimulated PBMC and whole blood, with PCA being more rapidly induced in PBMC. Further, LPS showed a difference between its induction of PCA in PBMC and whole blood, but it was not as pronounced as for the toxins. Whole blood represents of course the most in vivo-like situation and experimental set-ups (1 mg mL À1 ) for 4 h. IL-1b in the supernatants was determined by ELISA (pg mL À1 ). (C) PBMC were incubated with medium alone, IL-1b (500 pg mL À1 ), or EA (1 mg mL À1 ) in the absence or in the presence of IL-1Ra (100 ng mL À1 ) for 4 h. Thereafter clotting time was determined in recalci®ed human plasma. Values are means AE SD (n 3). Ã P < 0.05. using isolated cells rarely replicate the complex networks of interactions between humoral and cellular agents. The fact that speci®c antibodies to EA, EB and TSST-1 are present in most normal sera [27] could explain why higher concentrations of the toxins are needed to induce TF activity in whole blood, where neutralizing antibodies are present. In contrast, PBMC were stimulated by the toxins in arti®cial medium that lacks antibodies. Further, the whole blood assay contains coagulation factors and anticoagulant factors that are absent during the stimulatory phase of the PBMC assay. The continuous presence of coagulation factors in the whole blood assay could result in a change of their properties, or alternatively, there may be an activation of anticoagulant pathways. The ®rst suggestion is, however, unlikely since the clotting time remained unchanged in the controls during incubation time as long as 48 h. The ®nding that peptidoglycan induced the same PCA (dose±response and time kinetics) in the two assays rules out that minor differences in the ratio citrate and CaCl 2 in the assays should play a role (data not shown).
Since staphylococcal exotoxins can induce TNF-a, IL-1b, and IFN-g expression in PBMC and these cytokines can activate coagulation, we raised the question whether the toxin-induced PCA was a direct effect on the monocytes or was mediated by cytokines. TNF-a and IL-1b induced PCA in PBMC in a dosedependent manner, while IFN-g did not. Further, we were able to detect IL-1b in the supernatants from toxin-stimulated PBMC, but surprisingly only low amounts of TNF-a. To investigate possible roles for the cytokines further, toxin-stimulated PBMC were incubated in the absence or presence of IL-1Ra or neutralizing MoAb against TNF-a. The effect on PCA induced by the staphylococcal toxins was almost abrogated in the presence of IL-1Ra ( Fig. 4c ), but was not changed in the presence of MoAb against TNF-a (data not shown). This result explains ®ndings from in vivo studies. While TNF-a can induce TF expression on monocytes in vivo, it is not a key player in the activation of coagulation during sepsis. This has become evident from studies where pretreatment of volunteers and baboons with anti-TNF-a before exposure to endotoxin did not affect activation of coagulation but suggest an important function for TNF-a in triggering the ®brinolytic system [28, 29] . In contrast, administration of IL-1Ra resulted in inhibition of both the coagulation cascade and ®brinolysis in patients with sepsis [30] . These in vivo data emphasize the role of IL-1b as an activator of the coagulation system, in parallel to what is found in the in vitro experiments in the present study.
Clinical studies have illustrated that the in¯ammatory response and coagulation are linked systems in sepsis, and strict control of both systems is vital to the host [31, 32] . In these patients, activation of the extrinsic coagulation pathway triggered by TF induced increased coagulation activity [33] . TF pathway inhibitor, a naturally occurring inhibitor of TF, has proven to improve signi®cantly the mortality rate in models of superantigen-induced shock, and recently protein C, a naturally occurring inhibitor of proin¯ammatory cytokines and thrombin, infused to patients with severe sepsis resulted in a reduction of mortality rate [31±33].
The present investigation indicates that the superantigens EA, EB and TSST-1 from S. aureus induce little or no direct PCA in monocytes on their own, but act indirectly via the induction of IL-1b release from human PBMC. Greater knowledge of the host response against bacterial superantigens may elucidate novel therapeutic strategies in severe S. aureus infection.
